ShareValue scores for INDGN.NSE: Valuation 54, Quality 55, Growth 59, Health 57.

INDGN.NSE
NSE

Indegene Ltd

₹550.20(+1.83%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 17%
Valuation
54
Fair Value
Price vs Value
Quality
55
Moderate
Business Strength
Growth
59
Moderate
Revenue & Earnings
Health
57
Moderate
Financial Stability
Momentum
43
Neutral
Price Trend

Company Details

About

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026